Average Co-Inventor Count = 1.56
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. University of Pittsburgh (11 from 1,866 patents)
2. Johns Hopkins University (4 from 3,688 patents)
3. Gene Logic, Inc. (1 from 13 patents)
15 patents:
1. 7838251 - Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
2. 7598042 - Early prostate cancer antigens (EPCA), polynucleotide sequences encoding them, and their use
3. 7531634 - Bladder matrix protein peptides and methods of detection of bladder cancer
4. 7321830 - Identifying drugs for and diagnosis of benign prostatic hyperplasia using gene expression profiles
5. 7258991 - Antibody to bladder cancer nuclear matrix protein and its use
6. 7189823 - Antibody against illfdyfnr
7. 6951926 - Antibody to bladder cancer nuclear matrix protein and its use
8. 6617432 - Nuclear matrix proteins polynucleotide sequences encoding them and their use
9. 6280956 - Antibodies to bladder cancer nuclear matrix proteins and their use
10. 6232443 - Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use
11. 6030793 - Nuclear matrix proteins
12. 5874539 - Antibodies to nuclear matrix proteins
13. 5866535 - Bladder nuclear matrix proteins, polynucleotide sequences encoding them,
14. 5849509 - Nuclear matrix proteins
15. 5824490 - Method for detecting prostate cancer using a reagent which binds